Learn about the FDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) designed to curb opioid misuse by ensuring safe prescribing, dispensing, and patient monitoring practices. This initiative targets healthcare professionals and aims to improve patient safety and opioid education.